首页> 美国卫生研究院文献>Oncology Letters >Role of NKG2D in cytokine-induced killer cells against lung cancer
【2h】

Role of NKG2D in cytokine-induced killer cells against lung cancer

机译:NKG2D在细胞因子诱导的杀伤细胞对抗肺癌中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It has been previously demonstrated that cytokine-induced killer (CIK) cells possess potent cytotoxicity against various cancer cells, including lung cancer cells. However, the mechanism by which CIK cells recognize lung cancer cells has not been understood. The interaction between killer cell lectin like receptor K1 (NKG2D) receptor and NKG2D ligands was demonstrated to serve an important role in target cell killing by natural killer cells. The present study investigated whether NKG2D receptor and NKG2D ligand interactions are involved in the CIK-directed killing of lung cancer cells. The expression of MICA and ULBP2 was detected in tumor and healthy tissue samples. The expression of MICA and ULBP2 in tumor tissue samples was higher compared with that in the healthy control tissue. The expression of NKG2D ligands was analyzed in A549 and Q56 cells through reverse transcription-quantitative polymerase chain reaction and flow cytometry. The results demonstrated that the lung cancer cell lines markedly expressed the NKG2D ligands. Furthermore, NKG2D ligand-expressing lung cancer cells were targeted by CIK cells, which was partially blocked by treating CIK cells with an antibody against NKG2D. The data of the current study has demonstrated that the NKG2D-NKG2D ligand interaction serves an essential role in mediating lung cancer cell killing by CIK cells.
机译:先前已经证明,细胞因子诱导的杀伤(CIK)细胞对包括肺癌细胞在内的各种癌细胞具有有效的细胞毒性。但是,CIK细胞识别肺癌细胞的机制尚不清楚。已证明杀伤细胞凝集素样受体K1(NKG2D)受体与NKG2D配体之间的相互作用在自然杀伤细胞杀伤靶细胞中起重要作用。本研究调查了NKG2D受体和NKG2D配体的相互作用是否参与CIK定向杀伤肺癌细胞。在肿瘤和健康组织样品中检测到MICA和ULBP2的表达。与健康对照组织相比,肿瘤组织样品中MICA和ULBP2的表达更高。通过逆转录-定量聚合酶链反应和流式细胞仪分析了A549和Q56细胞中NKG2D配体的表达。结果表明,肺癌细胞系显着表达了NKG2D配体。此外,表达NKG2D配体的肺癌细胞被CIK细胞靶向,CIK细胞通过用抗NKG2D的抗体处理CIK细胞而被部分阻断。当前研究的数据表明,NKG2D-NKG2D配体相互作用在介导CIK细胞杀伤肺癌细胞中起着至关重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号